Investor Alert

Company Close Updates Archives | Email alerts

May 11, 2021, 4:31 p.m. EDT

Moderna Inc. stock rises Tuesday, outperforms market

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Moderna Inc. MRNA inched 0.28% higher to $158.99 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.09% to 13,389.43 and Dow Jones Industrial Average DJIA falling 1.36% to 34,269.16. Moderna Inc. closed $30.27 below its 52-week high ($189.26), which the company reached on February 8th.

The stock outperformed some of its competitors Tuesday, as AbbVie Inc. ABBV fell 1.14% to $114.89, Amgen Inc. AMGN fell 0.13% to $252.30, and AstraZeneca PLC ADR AZN fell 0.51% to $54.10. Trading volume (8.1 M) remained 1.9 million below its 50-day average volume of 10.0 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Moderna Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.